Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of the Coagulation Pathways in Recurrent Angioedema

NCT02892682 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT02892682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02892682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of the Coagulation Pathways in Recurrent Angioedema
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Terminated
Start date
May 31, 2016
Completion date
May 10, 2023
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic spotaneous urticaria, idiopathic non histaminergic angioderma, hereditary angioedema with c1 inhibitor deficiency